Milanova Tsveta Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$295,648.10

Insider Activity of Milanova Tsveta

According to the SEC Form 4 filings, Milanova Tsveta, being in a position of

  1. Chief Commercial Officer at Agios Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11934 shares for $353,311,
    over all time since 2023-06-30, has bought 0 shares, and sold 25327 shares for $741,865.

Biography of Milanova Tsveta

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $353,3114100

Comparison of Insiders on Amount of Buys and Sells

2026-04-02SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
3,262
0.0057%
$34.71$113,224-6.01%
2026-03-02SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,868
0.0047%
$28.96$83,057+11.95%
2026-01-05SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,872
0.0048%
$27.02$77,601+13.66%
2025-12-30SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,932
0.005%
$27.09$79,428+13.04%
2025-06-24SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,770
0.0048%
$33.54$92,906-9.55%
2025-03-03SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
1,681
0.0032%
$35.54$59,743-2.99%
2025-01-06SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,804
0.0047%
$32.18$90,233+1.51%
2024-01-24SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
1,618
0.0026%
$21.64$35,014+95.35%
2024-01-05SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
2,902
0.0048%
$22.32$64,773+81.63%
2023-06-30SaleAgios Pharmaceuticals, Inc.
AGIO
Chief Commercial Officer
1,618
0.0029%
$28.36$45,886-5.99%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.